Fibrates consistently lower risk of cardiovascular events across high-risk groups.
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D002995:Clofibric Acid / Q000627:therapeutic use*; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
D000960:Hypolipidemic Agents; D002995:Clofibric Acid